Seminars in Liver Disease

LinksSchließen

Referenz

Takaguchi K, Toyoda H, Tsutsui A. , et al.
Real-world virological efficacy and safety of daclatasvir/asunaprevir/beclabuvir in patients with chronic hepatitis C virus genotype 1 infection in Japan.

J Gastroenterol 2019;
54 (08) 742-751

Bibliographische Angaben herunterladen

Aufrufen in: